Crossmark

Investigator-initiated versus industry-sponsored trials – visibility and relevance of randomized controlled trials in clinical practice guidelines (IMPACT)

Crossref DOI link: https://doi.org/10.1186/s12874-025-02535-z

Published Online: 2025-03-27

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Hecht, Manuel

Blümle, Anette

Binder, Harald

Schumacher, Martin

Binder, Nadine
Funding

Funding for this research was provided by:

Deutsche Forschungsgemeinschaft (499552394, 499552394)

Universitätsklinikum Freiburg
License Information

Text and Data Mining valid from 2025-03-27

Version of Record valid from 2025-03-27
More Information

Article History

Received: 12 January 2025

Accepted: 20 March 2025

First Online: 27 March 2025

Declarations

:

: Not applicable.

: Not applicable.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below